Trials / Completed
CompletedNCT02866162
Screening for Genes in Patients With Congenital Neutropenia
Identification of the Molecular Bases of Syndromic Congenital Neutropenia With Development Anomalies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Syndromic congenital neutropenia (SCN) includes a heterogeneous group of diseases characterized by congenital neutropenia associated with the involvement of other organs. Most patients have syndromic congenital neutropenia, which does not correspond, either clinically or genetically, to any other previously described form. A large number of genes still have to be identified in these syndromic forms. The aim of this study is to identify the molecular bases of congenital neutropenias that have not yet been classified, by taking advantage of high-throughput exome sequencing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | High-throughput exome sequencing |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-09-01
- First posted
- 2016-08-15
- Last updated
- 2026-03-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02866162. Inclusion in this directory is not an endorsement.